When did CONMED report Q1 2026 earnings?

CONMED (CNMD) reported Q1 2026 earnings on April 29, 2026 after market close.

What were CONMED's Q1 2026 revenue and EPS?

CONMED reported revenue of $317.0M and eps of $0.89 for Q1 2026.

Did CONMED beat estimates in Q1 2026?

Revenue beat the consensus estimate of $310.6M by $6.4M. EPS beat the consensus estimate of $0.82 by $0.07.

How did CONMED's Q1 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue declined 1.3% from $321.3M a year earlier and eps declined 6.3% from $0.95.

Where can I find CONMED's Q1 2026 SEC filings?

You can read the 8-K earnings release (0000816956-26-000051) and the 10-Q periodic report (0000816956-26-000053) directly on SEC EDGAR. The filing index links above go to sec.gov.

CONMED CNMD Q1 2026 earnings

Reported April 29, 2026 · After market close

Revenue$317.0MBeat by $6.4M

EPS$0.89Beat by $0.07

Revenue estimate$310.6M

EPS estimate$0.82

Next report

Date not yet announced

Financials

Q1 2026

Income statement

See full

Revenue$317.0M-1.3%

Gross profit$183.4M+3.2%

Operating income$25.4M+59.3%

Net income$13.8M+129%

EPS (diluted)$0.45+137%

Balance sheet

See full

Cash & equivalents$35.0M-1.3%

Total debt$862.6M-3.6%

Total equity$1.0B+4.1%

Total assets$2.3B+0.8%

Cash flow

See full

Operating cash flow$13.5M-67.6%

CapEx$2.9M-23.5%

Free cash flow$10.6M-72.0%

Valuation & ratios

Valuation

as of 03/31/26

See full

Market cap$1.09B-41.6%

Enterprise value$1.92B-29.6%

P/E19.9×+4.2×

P/S0.8×-0.6×

Profitability

See full

Gross margin55.2%-1.0pp

Operating margin8.2%-5.6pp

Net margin4%-5.0pp

FCF margin9%-3.5pp

Returns & leverage

See full

Return on equity5.5%-7.5pp

Debt / equity0.8×-0.1×

Current ratio2.3×0.0×

Segments

By geography

See full

Europe, Middle East & Africa$69.1M+8.6%

Asia Pacific$42.0M-4.0%

Americas (excluding the United States)$32.9M+9.3%

By product

See full

General Surgery$169.4M-7.4%

Orthopedic Surgery$147.7M+6.8%

Versus estimates

Revenue

Q2 2026$343.5MBeat by $5.9M

Q1 2026$317.0MBeat by $6.4M

Q4 2025$373.2MBeat by $6.3M Q3 2025$337.9MMiss by $29.0M Q2 2025$342.3MBeat by $7.7M Q1 2025$321.3MBeat by $7.9M

Diluted EPS

Q2 2026$1.38Beat by $0.28

Q1 2026$0.89Beat by $0.07

Q4 2025$1.43Beat by $0.11 Q3 2025$1.08Beat by $0.03 Q2 2025$1.15Beat by $0.02 Q1 2025$0.95Beat by $0.14

Ask the moment CONMED reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did CONMED report Q1 2026 earnings?: CONMED (CNMD) reported Q1 2026 earnings on April 29, 2026 after market close.
What were CONMED's Q1 2026 revenue and EPS?: CONMED reported revenue of $317.0M and eps of $0.89 for Q1 2026.
Did CONMED beat estimates in Q1 2026?: Revenue beat the consensus estimate of $310.6M by $6.4M. EPS beat the consensus estimate of $0.82 by $0.07.
How did CONMED's Q1 2026 results compare year-over-year?: Compared to the same quarter a year prior, revenue declined 1.3% from $321.3M a year earlier and eps declined 6.3% from $0.95.
Where can I find CONMED's Q1 2026 SEC filings?: You can read the 8-K earnings release (0000816956-26-000051) and the 10-Q periodic report (0000816956-26-000053) directly on SEC EDGAR. The filing index links above go to sec.gov.